Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3590 studies found for:    "Carcinoma, Non-Small-Cell Lung"
Show Display Options
Rank Status Study
21 Completed Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer
Condition: Carcinoma, Non Small Cell Lung
Intervention: Drug: Sagopilone (BAY86-5302, ZK 219477)
22 Recruiting Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers
Condition: Carcinoma, Non-small Cell Lung
Interventions: Drug: Aprepitant;   Drug: placebo
23 Withdrawn TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Pemetrexed;   Drug: Cisplatin;   Drug: Bevacizumab
24 Recruiting Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers
Condition: Carcinoma, Non-small Cell Lung
Intervention: Drug: ethaselen
25 Terminated
Has Results
A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small Cell Lung
Interventions: Drug: Nexavar (Sorafenib, BAY43-9006) + carboplatin + paclitaxel;   Drug: Carboplatin plus Paclitaxel
26 Completed Temsirolimus and Radiation for Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Temsirolimus;   Radiation: Radiation therapy
27 Recruiting BIO 300 Non-Small Cell Lung Cancer Study
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BIO 300 Oral Suspension;   Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Radiotherapy
28 Terminated Docetaxel in Non Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Docetaxel
29 Terminated
Has Results
Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small Cell Lung
Intervention: Drug: Erlotinib plus Digoxin
30 Completed Study of Salirasib to Treat Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Salirasib
31 Completed Pharmacogenomic Study Realized on "Non-small Cell Lung Carcinoma"
Condition: Carcinoma, Non-Small-Cell Lung
Intervention:
32 Completed
Has Results
A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Sorafenib (Nexavar, BAY43-9006);   Drug: Placebo;   Drug: Gemcitabine;   Drug: Cisplatin
33 Completed A Study of XL184 (Cabozantinib) With or Without Erlotinib in Adults With Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: XL184;   Drug: erlotinib
34 Unknown  Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Erlotinib (Tarceva®)
35 Terminated Vaccine Maintenance Treatment for Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Biological: HyperAcute-Lung Cancer Vaccine
36 Completed
Has Results
Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer
Condition: Carcinoma, Non Small Cell Lung
Interventions: Drug: vorinostat;   Drug: bortezomib
37 Terminated MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: PD-0325901
38 Recruiting A Trial of AP32788 in Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: AP32788
39 Active, not recruiting
Has Results
AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: AMG 102 and erlotinib
40 Completed Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: docetaxel;   Drug: PI-88

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.